
Whole Grains · Whole grain
Oat Bran
Avena sativa · also called Oat bran cereal, salvado de avena (Spanish)
Oat bran is the outer layer of the oat grain, sold dry and eaten cooked as a hot cereal or added to baking. It is rich in a soluble fibre called beta-glucan, and pooled trials of oat beta-glucan show a small fall in LDL (bad) cholesterol that the FDA and EFSA both accept. Most other uses rest on small trials, and one fatty liver trial found no benefit. The main cautions are gluten cross-contact if you have celiac disease, gas if you add fibre too fast, and kidney diets.
General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made
About Oat Bran
Oat bran is the fibre-rich outer layer of the oat grain, eaten cooked or in baking. It is a healthy food, not a proven remedy. The best-supported finding is a small fall in LDL cholesterol from oat beta-glucan; other uses rest on small trials, and two trials found no extra benefit.
What it is
Oat bran comes from the oat plant (Avena sativa, grass family). The FDA defines it as a fraction of ground clean oat groats or rolled oats that has at least 5.5 percent beta-glucan and 16 percent total fibre by dry weight. It is sold dry and eaten cooked as a hot cereal or added to muffins and breads.
USDA data for cooked oat bran, per 100 g: 40 kcal, 3.21 g protein, 0.86 g fat and 2.6 g fibre. One cup cooked (219 g) has about 88 kcal, 7.0 g protein, 5.7 g fibre, 88 mg magnesium, 261 mg phosphorus, 2.1 mg manganese and 17 micrograms selenium. Raw dry oat bran is far denser (246 kcal, 17.3 g protein and 15.4 g fibre per 100 g) because cooked oat bran holds a lot of water, so compare cooked with cooked. USDA lists no beta-glucan value.
What the research shows
Cholesterol: three pooled analyses of randomised trials of oat beta-glucan found LDL cholesterol 0.19 to 0.27 mmol/L lower, with no clear effect on HDL cholesterol or triglycerides. EFSA (2010) found a cause-and-effect link, and the FDA allows a "may reduce the risk of heart disease" label claim for qualifying oat foods including oat bran. These are label rules, not personal advice. The trials mostly tested oat beta-glucan in oat foods and products, not oat bran alone, and LDL is a blood marker.
Other uses: small trials of oat bran found a lower blood sugar rise after meals, lower glucose in pregnant women with gestational diabetes (4 weeks) and lower blood pressure in 50 adults with hypertension (3 months). In a 6-week trial of 154 people and a 12-week trial of 48 people with fatty liver, oat bran added nothing to diet advice. Cohort studies link whole grains, including added bran, to less heart disease, but cannot prove cause.
Oat bran is a good fibre food, but most claims beyond cholesterol come from small or single trials.
Food versus extracts
This page is about oat bran as food. Isolated beta-glucan powders and extracts are different products. Most cholesterol trials used oat beta-glucan in foods and products, and the abstracts read do not separate oat bran from other oat foods. The compound avenanthramides has only lab and animal evidence for effects.
Portions
USDA gives 1 cup cooked (219 g, about 88 kcal) and 1 cup dry (94 g, about 231 kcal) as household portions. This page gives no amounts to eat. A dietitian or doctor can advise you, especially if you have celiac disease, kidney disease or take medicine for blood sugar, blood pressure or cholesterol.
At a glance
Traditional uses history, not proof
- Eaten cooked as a hot cereal and added to muffins and breads
- Long use as food is not proof that it treats any condition
Studied for research
- LDL cholesterol, moderate certainty (oat beta-glucan; regulators accept the link)
- Fibre for digestion, high certainty for the nutrient, no oat bran trial
- Heart disease and early death, low certainty (observational, whole grains as a group)
- Blood sugar after meals, low certainty (small, short trials)
- Blood pressure, very low certainty (one small trial)
- Weight and metabolic syndrome, evidence against added benefit (one trial)
- Fatty liver, evidence against added benefit (one small trial)
- Gut symptoms in quiet ulcerative colitis, very low certainty (one small trial)
Main compounds
- Dietary fibre
- Beta-glucan (soluble fibre)
- Avenanthramides
- Phosphorus and potassium
- Manganese and magnesium
Common forms
- Oat bran cooked as a hot cereal (USDA values for cooked oat bran)
- Dry oat bran (USDA values for raw oat bran)
- Oat bran added to baking (not in the USDA file)
- Beta-glucan extracts and powders are different products and are not covered
Research links: 2014 meta-analysis: oat beta-glucan and cholesterol (28 trials) · 2017 review: oats in celiac disease · 2025 trial: oat bran for fatty liver · Research Library · Genes & Biomarkers Library
What it is and its history
- Accepted scientific name
- Avena sativa
- Naming authority
- L. (GBIF accepted)
- Common names
- Oat bran (English); Oat bran cereal (English); Salvado de avena (Spanish)
- Family or group
- Poaceae (the grass family), as given by GBIF and the existing nutrient summary.
- Classification
- Plantae > Tracheophyta > Liliopsida > Poales > Poaceae > Avena > Avena sativa
- Native range
- Not verified from a source read.
- Habitat
- Not verified from a source read.
- What it looks like
- Roots: Not verified.; Stems: Not verified.; Leaves: Not verified.; Flowers: Not verified.; Fruit: The oat grain; oat bran is its outer layer after milling. The FDA rule defines oat bran as a fraction of ground clean oat groats or rolled oats that is not more than 50 percent of the starting material and has at least 5.5 percent beta-glucan and 16 percent total fibre by dry weight.
- Cultivation
- Not verified from a source read.
- Harvest and processing
- Oat bran is made by grinding clean oat groats or rolled oats and separating the bran fraction (FDA definition). It is sold dry and eaten cooked as a hot cereal or added to baking. Instant packets and baked goods can contain added sugar, salt, wheat, milk or nuts: read the label.
- Look-alikes and adulterants
- Name: Rolled oats, oatmeal and oat flour; Note: The whole oat grain products. USDA lists 10.1 g fibre per 100 g dry regular oats against 15.4 g in raw oat bran.; Name: Wheat bran, spelt bran; Note: Other brans; a spelt bran arm was tested in the fatty liver trial.; Name: Isolated oat beta-glucan products; Note: Extracts and powders are a different product from the food and are not covered by the food results here.
- Sustainability and conservation
- Not assessed.
Photographs

What is inside, and how it may work
What it contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.
Main compounds
| Compound | Family | Where it is concentrated | Activity studied | Level of evidence |
|---|---|---|---|---|
| Dietary fibre | carbohydrate | Grain bran layer USDA: 15.4 g per 100 g raw; 2.6 g per 100 g cooked | Adds bulk and helps digestion (MedlinePlus). 22 23 17 | Human data |
| Beta-glucan (oat beta-glucan) | soluble fibre | Grain bran layer FDA definition: at least 5.5% of oat bran by dry weight. USDA lists no beta-glucan value. In one fatty liver trial the oat bran arm gave 4.5 g beta-glucan with 11.7 g fibre a day. | A viscous soluble fibre. Pooled trials found it lowers LDL cholesterol and, in small studies, the blood sugar rise after meals. 15 9 4 10 3 | Human data |
| Avenanthramides | phenolic amides (oat-specific) | Oat grain Not found in sources read | Affect inflammation and sugar and fat pathways in cells and animals; no human effect specific to them was shown. 13 | Lab and animal |
| Phosphorus and potassium | minerals | Grain USDA per 100 g raw: 734 mg phosphorus, 566 mg potassium; cooked: 119 mg and 92 mg | Relevant for people on kidney-diet limits. 22 23 21 | Composition data |
Mechanisms, receptors and pathways
| Target or pathway | Gene or receptor | What was found | Level |
|---|---|---|---|
| Soluble fibre and blood fats | Not specified in the sources read | Pooled human trials show oat beta-glucan lowers LDL cholesterol; EFSA said there was strong evidence supporting biological plausibility. The steps were not read in detail. 14 9 | Human data |
| Viscous fibre and after-meal blood sugar | Not specified | The authors of a crossover trial say viscous fibres change how glucose is absorbed. This is their explanation, not tested in that trial. 10 | Human (interpretation) |
| Colon butyrate | Not specified | In people with ulcerative colitis in remission, oat bran raised fecal butyrate. 6 | Human data |
| Avenanthramides, inflammation and metabolism | NF-kB pathway (cell and animal work) | Seen in cell and animal models only; no human avenanthramide-specific effect established. 13 | Lab and animal |
Absorption, metabolism and elimination
- Absorption
- Not found for oat bran. Humans absorb avenanthramides from oats (2026 review); oat beta-glucan itself is a fibre that is fermented in the gut.
- Distribution
- Not found.
- Metabolism
- Not found.
- Elimination
- Not found.
- Bioavailability
- Not established for oat bran nutrients in the sources read.
Isolated compounds versus whole extracts
The cholesterol evidence is mostly for oat beta-glucan in oat foods and products, and the abstracts read do not separate oat bran. The trials of oat bran itself (blood pressure, gestational diabetes, metabolic syndrome, fatty liver, colitis) used 30 to 40 g a day or a fixed fibre amount and are small. Extracts and beta-glucan powders are a different product.
Nutritional composition
Nutrition from USDA FoodData Central (SR Legacy, April 2018 release; values read 2026-10-26 from a saved copy of the data feed because the public API was rate-limited). Cooked oat bran (FDC 168873), per 100 g: 40 kcal, 3.21 g protein, 0.86 g fat, 0.163 g saturated fat, 11.44 g carbohydrate, 2.6 g fibre, 1 mg sodium, 92 mg potassium, 119 mg phosphorus, 40 mg magnesium, 0.964 mg manganese, 7.7 micrograms selenium, 0.88 mg iron, 0.53 mg zinc, 0.16 mg thiamin. One cup of cooked oat bran (219 g): about 88 kcal, 7.0 g protein, 1.9 g fat, 5.7 g fibre, 87.6 mg magnesium, 261 mg phosphorus, 201 mg potassium, 2.1 mg manganese, 16.9 micrograms selenium, 1.9 mg iron, 1.2 mg zinc and 0.35 mg thiamin (the per-100-g values multiplied by 2.19). Raw dry oat bran (FDC 168872), per 100 g: 246 kcal, 17.3 g protein, 7.03 g fat, 66.22 g carbohydrate, 15.4 g fibre, 566 mg potassium, 734 mg phosphorus, 235 mg magnesium, 5.63 mg manganese, 45.2 micrograms selenium, 5.41 mg iron, 3.11 mg zinc, 1.17 mg thiamin; one dry cup (94 g) is about 231 kcal and 14.5 g fibre. Cooked and dry numbers differ because cooked oat bran holds a lot of water, so compare cooked with cooked. For comparison USDA lists dry regular oats (FDC 173904) at 379 kcal, 13.15 g protein and 10.1 g fibre per 100 g, and oats cooked with water (FDC 173905) at 71 kcal and 1.7 g fibre per 100 g. USDA lists no beta-glucan value for oat bran. Values vary with oat variety, milling and recipe; instant packets and baked goods differ.
1 high certainty1 moderate certainty2 low certainty2 very low certainty1 not enough evidence2 evidence against
What was looked at
The 9 benefits and uses checked for Oat Bran, each with how strong the evidence is. Tap one to open it.
- LDL cholesterol (oat beta-glucan)Moderate certainty
- Heart disease and early death (whole grains, observational)Low certainty
- Fibre for digestion (nutrient fact)High certainty
- Blood sugar after meals and in gestational diabetesLow certainty
- Blood pressureVery low certainty
- Weight and metabolic syndromeEvidence against
- Fatty liver disease (MASLD)Evidence against
- Gut symptoms in quiet ulcerative colitisVery low certainty
- Oat-specific plant compounds (avenanthramides)Not enough evidence
Lab markers tracked in the studies
LDL cholesterolTotal cholesterolHDL cholesterol and triglyceridesBlood sugar after a mealBlood pressureLiver fat (CAP)
What is Oat Bran good for?
The main studied uses and how strong the human evidence is for each. The cholesterol evidence is for oat beta-glucan in general; the oat bran trials are small.
Benefits, one by one
Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.
LDL cholesterol (oat beta-glucan)
Moderate certaintyPooled trials of oat beta-glucan found LDL ("bad") cholesterol about 0.19 to 0.27 mmol/L lower than control diets. US and EU regulators both accept the link for oat beta-glucan. Oat bran is a rich source, but most trials were of oat beta-glucan in general, not oat bran alone.
6 studiesOat beta-glucan from oat foods and products. The FDA and EFSA levels …
Studies, doses and limits
What the trials found
A meta-analysis of 28 randomised trials found at least 3 g a day of oat beta-glucan lowered LDL by 0.25 mmol/L and total cholesterol by 0.30 mmol/L. A larger review of 58 trials (3,974 people) found a median 3.5 g a day lowered LDL by 0.19 mmol/L, with considerable differences between trials. A review of 13 trials in people with raised cholesterol found LDL 0.27 mmol/L lower. EFSA (2010) found a cause-and-effect link between oat beta-glucan and lower LDL, and the US FDA allows a heart-disease label claim for foods that include oat bran meeting its definition.
Results
LDL fell a small amount on average. Effects were larger when starting LDL was higher. No clear effect on HDL cholesterol or triglycerides. One small trial of oat bran in people with quiet ulcerative colitis also found lower LDL than a low-fibre wheat diet.
Effect sizes as reported
LDL -0.25 mmol/L (95% CI -0.30 to -0.20) in 28 trials; -0.19 mmol/L (-0.23 to -0.14) in 58 trials; -0.27 mmol/L (-0.35 to -0.20) in 13 trials.
Why this rating
Several meta-analyses of randomised trials agree and two regulators accept the link. Lowered because trials were of oat beta-glucan in general (not oat bran alone), differ a lot from each other in one review, the EFSA application came from an oat-beta-glucan company, and LDL is a blood marker, not proof of fewer heart attacks.
Form and dose studied
Oat beta-glucan from oat foods and products. The FDA and EFSA levels are label rules for foods, not personal advice.
Who was studied
Adults, including people with raised cholesterol.
Limits
Oat bran is not separated from other oat foods in the abstracts read. Blood marker only. Isolated beta-glucan extracts are a different product.
Why researchers looked
Oat bran is a concentrated source of beta-glucan, a soluble fibre, so it is the food most often tested for cholesterol.
Traditional use
Oat bran is eaten as a hot cereal and added to muffins and breads. Long use as food is not proof that it treats any condition.
Proposed mechanism Authoritative guidance
Soluble fibre forms a gel and slows digestion; MedlinePlus lists this as how it helps lower cholesterol. The exact steps for oat beta-glucan were not read.
A proposed mechanism does not show that the effect happens in people.
Oat bran is a fibre food: see Safety for gas and bloating, gluten cross-contact and kidney cautions.
Heart disease and early death (whole grains, observational)
Low certaintyPeople who eat more whole grains, including added bran, had less heart disease and lived longer in studies that followed people over time. These studies cannot prove cause, and they are about whole grains as a group, not oat bran alone.
1 studiesWhole grain foods as eaten in cohorts (statistical comparison, not ad…
Studies, doses and limits
What the trials found
A 2016 BMJ meta-analysis of 45 prospective studies found that, per 90 g a day more whole grain, coronary heart disease risk was 19% lower (RR 0.81) and cardiovascular disease risk 22% lower (RR 0.78); stroke (RR 0.88) did not clearly differ. Whole grain bread, whole grain breakfast cereals and added bran were each linked to lower risk of cardiovascular disease and/or death from any cause.
Results
Associations, not proof. Healthy people tend to eat healthier overall, which these studies cannot fully remove. Oat bran was not reported separately in the abstract.
Effect sizes as reported
Per 90 g/day more whole grain: coronary heart disease RR 0.81 (0.75 to 0.87); cardiovascular disease RR 0.78 (0.73 to 0.85); all-cause mortality RR 0.83 (0.77 to 0.90).
Why this rating
Observational cohorts, whole grains as a group, not oat bran.
Form and dose studied
Whole grain foods as eaten in cohorts (statistical comparison, not advice).
Who was studied
Adults followed for years.
Limits
Cannot show cause. Oat bran not separated.
Why researchers looked
Whole grains are a common part of heart-healthy eating patterns.
Traditional use
Whole grains are staple foods in many diets.
Proposed mechanism Unknown
Not established in the abstract.
A proposed mechanism does not show that the effect happens in people.
None specific.
Fibre for digestion (nutrient fact)
High certaintyRaw oat bran has 15.4 g of fibre per 100 g and cooked oat bran 2.6 g per 100 g (5.7 g per cup), by USDA data. MedlinePlus says fibre adds bulk, helps digestion and helps prevent constipation. This is a nutrient fact, not a trial of oat bran.
4 studiesOat bran as food.
Studies, doses and limits
What the trials found
USDA lists 15.4 g of total fibre per 100 g raw oat bran and 2.6 g per 100 g cooked. For comparison, USDA lists 10.1 g per 100 g for dry regular oats and 1.7 g per 100 g for oats cooked with water. No trial of oat bran for constipation was read.
Results
Oat bran is a good source of fibre. No oat bran constipation trial was read.
Effect sizes as reported
USDA: 15.4 g fibre per 100 g raw; 2.6 g per 100 g cooked; about 5.7 g in one cooked cup (219 g).
Why this rating
High that oat bran contains fibre (USDA data) and that fibre helps digestion (MedlinePlus). No trial of oat bran itself for bowel function was read.
Form and dose studied
Oat bran as food.
Who was studied
General adult diet.
Limits
A nutrient fact. USDA does not split soluble and insoluble fibre.
Why researchers looked
Oat bran is a well-known fibre food.
Traditional use
Oat bran is eaten as a hot cereal and in baking.
Proposed mechanism Authoritative guidance
Fibre adds bulk and helps digestion (MedlinePlus).
A proposed mechanism does not show that the effect happens in people.
Adding fibre too fast can cause gas, bloating and cramps (see Safety).
Blood sugar after meals and in gestational diabetes
Low certaintyIn small, short studies, oat bran in a meal or drink lowered the blood sugar rise after eating. In one 4-week trial of 112 pregnant women with diet-treated gestational diabetes, fasting and after-meal glucose were lower with oat bran added. The studies are small and short.
3 studiesOat bran as food or in a drink (trial detail, not advice).
Studies, doses and limits
What the trials found
In 40 healthy adults, adding oat bran to instant oatmeal lowered the blood sugar response in a dose-related way (about 7% lower response and 15% lower peak per gram of added oat beta-glucan). In 20 people, malt drinks made with oat bran gave a 26% to 38% lower three-hour blood sugar response than a drink without it (Nestle-funded). In 112 women with gestational diabetes, 30 g oat bran a day for 4 weeks went with lower fasting and 2-hour glucose than diet alone (P < 0.001).
Results
Short-term lowering of after-meal blood sugar in healthy people, and a lower glucose in one trial in gestational diabetes. No long-term trial of oat bran on HbA1c was read.
Effect sizes as reported
About 7% (response) and 15% (peak) per gram of added oat beta-glucan in healthy adults; 26% to 38% lower response in a drink trial; gestational-diabetes trial reported P < 0.001 without numbers in the abstract.
Why this rating
Small and short trials; the healthy-adult studies are single meals; one is industry-funded; the pregnancy trial lacks effect sizes in the abstract.
Form and dose studied
Oat bran as food or in a drink (trial detail, not advice).
Who was studied
Healthy adults; women with gestational diabetes.
Limits
Not long-term, not in type 2 diabetes. Not a treatment for diabetes.
Why researchers looked
Beta-glucan is a thick soluble fibre that slows how sugar enters the blood.
Traditional use
Oat bran is eaten as a hot cereal and in baking.
Proposed mechanism Unknown
The authors of one trial say viscous fibres change how glucose is absorbed. This was the authors' explanation, not tested in that trial.
A proposed mechanism does not show that the effect happens in people.
People using medicine for diabetes should ask their clinic before big diet changes.
Blood pressure
Very low certaintyOne small 3-month trial in 50 adults with high blood pressure found lower blood pressure readings with 30 g of oat bran a day added to diet advice. One small trial is not enough to conclude.
1 studiesOat bran 30 g a day in the trial (trial detail, not advice).
Studies, doses and limits
What the trials found
In 50 adults with essential hypertension, oat bran (30 g a day, 8.9 g fibre) for 3 months went with lower office and 24-hour blood pressure than diet guidance alone, and less blood pressure medicine was used in the oat bran group (P = 0.021).
Results
Lower readings in one small trial. Size of the change was not in the abstract.
Effect sizes as reported
Office systolic P < 0.001, office diastolic P = 0.028; numbers of mmHg not in the abstract.
Why this rating
A single small trial, not placebo-controlled, no blood pressure numbers in the abstract.
Form and dose studied
Oat bran 30 g a day in the trial (trial detail, not advice).
Who was studied
Adults with essential hypertension.
Limits
One trial of 50 people. Blood pressure medicine should never be changed without a clinician.
Why researchers looked
Low fibre intake has been linked to higher blood pressure.
Traditional use
Oat bran is eaten as a hot cereal and in baking.
Proposed mechanism Unknown
Not established in the abstract.
A proposed mechanism does not show that the effect happens in people.
Do not change blood pressure medicine yourself; ask your clinician.
Weight and metabolic syndrome
Evidence againstIn a 6-week trial of 154 people on a low-calorie diet, adding 40 g a day of oat bran gave no extra benefit on weight, waist, blood pressure, blood fats or metabolic syndrome, and HDL ("good") cholesterol fell within the oat bran group.
1 studiesOat bran 40 g a day in the trial (trial detail, not advice).
Studies, doses and limits
What the trials found
Both groups improved by a similar amount on a low-calorie diet. Metabolic syndrome prevalence after follow-up was 63% with oat bran and 64.8% without (P = 0.226). HDL fell from 43.6 to 41.2 mg/dL in the oat bran group (P = 0.025) but not in the control group; the between-group difference was not statistically significant (P = 0.078).
Results
No added benefit on weight or metabolic syndrome. A possible small HDL drop that did not reach significance between groups.
Effect sizes as reported
No between-group difference; HDL change within oat bran group -2.4 mg/dL.
Why this rating
One open-label randomised trial found no added benefit and a within-group fall in HDL. A single 6-week trial is small evidence either way.
Form and dose studied
Oat bran 40 g a day in the trial (trial detail, not advice).
Who was studied
Outpatient adults with metabolic syndrome.
Limits
Open-label, 6 weeks, one centre.
Why researchers looked
Fibre can make meals more filling, so researchers ask whether it adds to a diet.
Traditional use
Oat bran is eaten as a hot cereal and in baking.
Proposed mechanism Unknown
Not established in the abstract.
A proposed mechanism does not show that the effect happens in people.
None specific.
Fatty liver disease (MASLD)
Evidence againstIn a 12-week double-blind trial of 48 adults with fatty liver, added oat bran gave no added benefit over the diet advice that every group received.
1 studiesOat bran in the trial arm (trial detail, not advice).
Studies, doses and limits
What the trials found
Dietary assessment alone lowered BMI and liver enzymes in the run-in phase, and improvements held in all groups. There were no significant changes in liver fat, overall gut bacteria or bile acids with oat bran (4.5 g beta-glucan, 11.7 g fibre a day), spelt bran or placebo.
Results
No added benefit from fibre.
Effect sizes as reported
No significant change in liver fat (CAP).
Why this rating
One small double-blind placebo-controlled trial found no benefit.
Form and dose studied
Oat bran in the trial arm (trial detail, not advice).
Who was studied
Adults with MASLD and no fibrosis.
Limits
Small trial, three groups of 48 people in total.
Why researchers looked
Fibre could change gut bacteria, which might affect the liver.
Traditional use
Oat bran is eaten as a hot cereal and in baking.
Proposed mechanism Controlled trial
The researchers tested gut bacteria and bile acids; neither changed.
A proposed mechanism does not show that the effect happens in people.
None specific.
Gut symptoms in quiet ulcerative colitis
Very low certaintyIn a 24-week trial of 94 people with ulcerative colitis in remission, oat bran products raised stool butyrate (a gut fibre by-product) and gut symptoms did not worsen, while they got worse on low-fibre wheat. Relapse rates were the same.
1 studiesOat bran products (amount not in the abstract).
Studies, doses and limits
What the trials found
The oat bran group had higher fecal butyrate and lower serum LDL. The control (low-fibre wheat) group had more obstipation, reflux and symptoms. The relapse rate was the same. The authors concluded oat bran was well tolerated.
Results
Symptoms did not worsen with oat bran. The control diet may have contributed to the difference.
Effect sizes as reported
Fecal butyrate and LDL differences P < 0.05; relapse rate same.
Why this rating
One small trial against a low-fibre control diet; blinding not stated.
Form and dose studied
Oat bran products (amount not in the abstract).
Who was studied
Adults with ulcerative colitis in remission.
Limits
Not a treatment for colitis; relapse was not reduced.
Why researchers looked
Oat fibre is fermented in the gut to butyrate, which feeds the cells of the colon.
Traditional use
Oat bran is eaten as a hot cereal and in baking.
Proposed mechanism Controlled trial
The authors link oat bran with higher colon butyrate.
A proposed mechanism does not show that the effect happens in people.
People with bowel disease should ask their gastroenterologist.
Oat-specific plant compounds (avenanthramides)
Not enough evidenceOats contain avenanthramides. In cells and animals they affect inflammation pathways, but a 2026 review found no human study showing an effect specific to them on body fat, liver fat, insulin sensitivity or blood fats.
1 studiesNot applicable.
Studies, doses and limits
What the trials found
The 2026 review says human studies show people are exposed to avenanthramides from oats. It found no human avenanthramide-specific effect.
Results
Lab and animal findings only.
Why this rating
Lab and animal findings; no human effect shown.
Limits
Narrative review of mostly cell and animal work.
Why researchers looked
They are unique to oats, so researchers ask whether they add to the effect of beta-glucan.
Traditional use
Present in oats eaten as food.
Proposed mechanism Preliminary mechanism
In cell and animal models they affect inflammation (NF-kB), antioxidant, liver sugar and fat pathways.
A proposed mechanism does not show that the effect happens in people.
None specific.
Connections to the rest of health
How Oat Bran connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.
Explore every connection: goals, body systems, organs, symptoms, genes
A. Wellness goals
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Cholesterol Balance | Demonstrated clinical effect | Moderate certainty | LDL cholesterol (oat beta-glucan): Pooled trials of oat beta-glucan found LDL ("bad") cholesterol about 0.19 to 0.27 mmol/L lower than control diets. US and EU regulators both accept the link for oat beta-glucan. Oat bran is a rich source, but most trials were of oat beta-glucan in general, not oat bran alone. | 9 4 12 14 15 6 |
| Heart Health | Demonstrated clinical effect | Moderate certainty | LDL cholesterol (oat beta-glucan): Pooled trials of oat beta-glucan found LDL ("bad") cholesterol about 0.19 to 0.27 mmol/L lower than control diets. US and EU regulators both accept the link for oat beta-glucan. Oat bran is a rich source, but most trials were of oat beta-glucan in general, not oat bran alone. | 9 4 12 14 15 6 |
| Heart Health | Low certainty | Heart disease and early death (whole grains, observational): People who eat more whole grains, including added bran, had less heart disease and lived longer in studies that followed people over time. These studies cannot prove cause, and they are about whole grains as a group, not oat bran alone. | 1 | |
| Digestive Support | Demonstrated clinical effect | High certainty | Fibre for digestion (nutrient fact): Raw oat bran has 15.4 g of fibre per 100 g and cooked oat bran 2.6 g per 100 g (5.7 g per cup), by USDA data. MedlinePlus says fibre adds bulk, helps digestion and helps prevent constipation. This is a nutrient fact, not a trial of oat bran. | 17 23 22 24 |
| Blood Sugar Balance | Low certainty | Blood sugar after meals and in gestational diabetes: In small, short studies, oat bran in a meal or drink lowered the blood sugar rise after eating. In one 4-week trial of 112 pregnant women with diet-treated gestational diabetes, fasting and after-meal glucose were lower with oat bran added. The studies are small and short. | 10 8 2 | |
| Blood Pressure Support | Very low certainty | Blood pressure: One small 3-month trial in 50 adults with high blood pressure found lower blood pressure readings with 30 g of oat bran a day added to diet advice. One small trial is not enough to conclude. | 11 | |
| Weight Management | Evidence against | Weight and metabolic syndrome: In a 6-week trial of 154 people on a low-calorie diet, adding 40 g a day of oat bran gave no extra benefit on weight, waist, blood pressure, blood fats or metabolic syndrome, and HDL ("good") cholesterol fell within the oat bran group. | 5 | |
| Liver Support | Evidence against | Fatty liver disease (MASLD): In a 12-week double-blind trial of 48 adults with fatty liver, added oat bran gave no added benefit over the diet advice that every group received. | 3 | |
| Gut Health | Very low certainty | Gut symptoms in quiet ulcerative colitis: In a 24-week trial of 94 people with ulcerative colitis in remission, oat bran products raised stool butyrate (a gut fibre by-product) and gut symptoms did not worsen, while they got worse on low-fibre wheat. Relapse rates were the same. | 6 | |
| Weight Management | Preliminary mechanism | Not enough evidence | Oat-specific plant compounds (avenanthramides): Oats contain avenanthramides. In cells and animals they affect inflammation pathways, but a 2026 review found no human study showing an effect specific to them on body fat, liver fat, insulin sensitivity or blood fats. | 13 |
B. Body systems
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Cardiovascular System | Biological association | Moderate certainty | Studied for: LDL cholesterol (oat beta-glucan) Studied for: Heart disease and early death (whole grains, observational) | 9 4 12 14 15 6 1 11 |
| Digestive System | Biological association | High certainty | Studied for: Fibre for digestion (nutrient fact) Studied for: Fatty liver disease (MASLD) | 17 23 22 24 3 6 |
| Endocrine System | Biological association | Low certainty | Studied for: Blood sugar after meals and in gestational diabetes | 10 8 2 |
| Metabolism Weight | Biological association | Low certainty | Studied for: Blood sugar after meals and in gestational diabetes Studied for: Weight and metabolic syndrome | 10 8 2 5 13 |
C. Body parts and organs
E. Health conditions
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Celiac disease | Adverse effect or risk | Documented risk | Oats can pick up gluten from wheat, barley or rye; a small number of people with celiac disease react to pure oats. Preparation or compound: Gluten cross-contact in oat products |
19 20 7 |
| Kidney disease | Documented risk | People on restricted diets should ask their kidney team. Oat bran contains phosphorus and potassium; people on restricted diets should ask their kidney team. Preparation or compound: Phosphorus and potassium in oat bran |
21 22 |
I. Biomarkers
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| LDL cholesterol | Biological association | Moderate certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 9 4 12 |
| Total cholesterol | Biological association | Moderate certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 9 12 |
| HDL cholesterol and triglycerides | Biological association | Moderate certainty | Measured in trials: no clear change. A lab change is not the same as a health benefit. | 9 12 |
| Blood sugar after a meal | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 10 8 2 |
| Blood pressure | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 11 |
| Liver fat (CAP) | Biological association | Low certainty | Measured in trials: no change. A lab change is not the same as a health benefit. | 3 |
K. Biological pathways
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Soluble fibre (beta-glucan) | Preliminary mechanism | Human | Oat beta-glucan lowers LDL cholesterol in pooled trials. | 9 4 |
| LDL cholesterol | Preliminary mechanism | Human | Lowered by about 0.19 to 0.27 mmol/L in pooled trials of oat beta-glucan. | 9 4 12 |
| Phosphorus and potassium | Preliminary mechanism | Composition data | Present in oat bran; relevant for kidney diets. | 22 21 |
L. Active compounds
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Dietary fibre | Biological association | Human | Adds bulk and helps digestion (MedlinePlus). Preparation or compound: Grain bran layer |
22 23 17 |
| Beta-glucan (oat beta-glucan) | Biological association | Human | A viscous soluble fibre. Pooled trials found it lowers LDL cholesterol and, in small studies, the blood sugar rise after meals. Preparation or compound: Grain bran layer |
15 9 4 10 3 |
| Avenanthramides | Biological association | Lab and animal | Affect inflammation and sugar and fat pathways in cells and animals; no human effect specific to them was shown. Preparation or compound: Oat grain |
13 |
| Phosphorus and potassium | Biological association | Composition data | Relevant for people on kidney-diet limits. Preparation or compound: Grain |
22 23 21 |
Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 26, 2026).
The evidence
The research centre for Oat Bran. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.
Evidence by outcome
Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).
How we rate evidence
High certainty
Several well-run trials or reviews agree; further research is unlikely to change the picture much.
Moderate certainty
Good trials point the same way, but some doubt remains.
Low certainty
Small, short or inconsistent trials. The finding could change with better research.
Very low certainty
Very little or very weak human data. Treat as a possibility only.
Mixed findings
Trials or reviews disagree with each other.
Not enough evidence
Not enough human research to say either way.
Evidence against
Good research found no benefit, or found harm.
We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We started from our existing oat bran summary, re-checked nutrition against saved USDA FoodData Central data, read the FDA rule, the EFSA abstract and the NHS, NIDDK, MedlinePlus and WHO pages, and re-read PubMed abstracts for reviews and trials. Only abstracts were read for studies. Items we could not verify are flagged in the research gaps. The EFSA application and one pooled review involved an oat beta-glucan company; one blood sugar trial was funded by Nestle.
Study library: every study we checked 25
| Study | Design | People | Product, dose, length | Result |
|---|---|---|---|---|
| Aune 2016 Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. BMJ · PMID 27301975 · DOI |
Systematic review (observational cohort studies) |
45 prospective studies (64 publications) of whole grain intake | Whole grains as a group, including whole grain breakfast cereals and added bran Whole grain foods Risk per 90 g a day more whole grain (statistical comparison, not advice) Follow-up years in cohorts · vs Lower intake |
Per 90 g a day more whole grain: coronary heart disease RR 0.81, cardiovascular disease RR 0.78, all-cause mortality RR 0.83; stroke RR 0.88 with an interval that included no effect. Added bran, whole grain bread and whole grain breakfast cereals were each linked to lower risk of cardiovascular disease and/or all-cause mortality. Oat bran was not reported separately in the abstract. RR 0.81 (CHD); 0.78 (CVD); 0.83 (all-cause mortality); 0.88 (stroke, not significant) (CHD 0.75 to 0.87; CVD 0.73 to 0.85; all-cause 0.77 to 0.90; stroke 0.75 to 1.03) Methods, limits and fundingOutcomes: Coronary heart disease, stroke, cardiovascular disease, cancer, all-cause mortality Limitations: Observational, so it cannot prove cause; whole grains as a group. Heterogeneity moderate to high for some outcomes (I2 83% for all-cause mortality). Funding and conflicts: No funding or financial conflicts declared for the submitted work. Read: abstract |
| Barati 2021 The effect of oat bran consumption on gestational diabetes: a randomized controlled clinical trial. BMC Endocr Disord · PMID 33849494 · DOI |
Controlled trial |
112 112 women with gestational diabetes treated with diet (56 per group) |
Oat bran added to a gestational-diabetes diet Oat bran 30 g a day at lunch and dinner (trial detail, not advice) 4 weeks · vs Gestational-diabetes diet alone |
Fasting and 2-hour after-meal glucose were lower in the oat bran group than in the control group at 2 and 4 weeks (P < 0.001). The authors call for larger studies. Lower fasting and 2-hour glucose (numbers not in the abstract) (Not given in the abstract) Methods, limits and fundingOutcomes: Fasting blood glucose and 2-hour after-meal glucose Limitations: Four weeks only; effect sizes are not in the abstract; no blinding stated; one centre in Iran. Funding and conflicts: No conflict of interest declared. Registered IRCT20191220045828N1. Registration: IRCT20191220045828N1 Read: abstract |
| Brandt 2025 Fiber enrichment is not superior to dietary monitoring in MASLD: A dual-center, double-blind, placebo-controlled trial. iScience · PMID 41438070 · DOI |
Controlled trial |
48 48 adults with fatty liver disease (MASLD) and no fibrosis |
Oat bran (4.5 g oat beta-glucan, 11.7 g total fibre a day), spelt bran (11.7 g fibre a day) or placebo (2.1 g fibre a day) Oat bran or spelt bran Oat bran arm: 4.5 g beta-glucan and 11.7 g fibre a day (trial detail, not advice) 12 weeks (after a 3-week run-in) · vs Placebo and dietary monitoring |
During the run-in, dietary assessment alone lowered BMI and liver enzymes, and the improvements were kept in all three groups. There were no significant changes in liver fat, overall gut bacteria or bile acids with the fibre, so the fibre gave no added benefit. No added benefit from fibre (Not given in the abstract) Methods, limits and fundingOutcomes: Liver fat (CAP), BMI, liver enzymes, gut bacteria, bile acids Limitations: Small (48 people, three groups); results are for oat bran and spelt bran combined in the discussion of fibre. No benefit shown. Funding and conflicts: No competing interests declared. Registered NCT03897218. Registration: NCT03897218 Read: abstract |
| Ho 2016 The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr · PMID 27724985 · DOI |
Systematic review meta analysis |
3974 58 randomised trials, 3,974 people |
Diets enriched with oat beta-glucan Oat beta-glucan in oat foods Median 3.5 g of beta-glucan a day (trial detail, not advice) At least 3 weeks · vs Control diets |
A median 3.5 g a day of oat beta-glucan lowered LDL cholesterol, non-HDL cholesterol and apoB compared with control. Heterogeneity between trials was considerable. LDL -0.19 mmol/L; non-HDL -0.20 mmol/L; apoB -0.03 g/L (LDL 95% CI -0.23 to -0.14; non-HDL -0.26 to -0.15; apoB -0.05 to -0.02) Methods, limits and fundingOutcomes: LDL cholesterol, non-HDL cholesterol, apoB Limitations: Considerable unexplained heterogeneity (I2 = 79% for LDL, 99% for non-HDL). Oat beta-glucan in general, not oat bran alone. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Leao LSCS 2019 Addition of oat bran reduces HDL-C and does not potentialize effect of a low-calorie diet on remission of metabolic syndrome: A pragmatic, randomized, controlled, open-label nutritional trial. Nutrition · PMID 31082790 · DOI |
Controlled trial |
154 154 outpatients with metabolic syndrome (83 oat bran, 71 control) |
Low-calorie diet plus oat bran Oat bran 40 g a day (trial detail, not advice) 6 weeks · vs Low-calorie diet alone |
Both groups improved by a similar amount, so oat bran added no extra benefit on metabolic syndrome or the related measures. HDL cholesterol fell within the oat bran group (43.6 to 41.2 mg/dL, P = 0.025) but not in the control group; the difference between groups was not statistically significant (P = 0.078). No between-group difference; HDL fell within the oat bran group only (Between-group HDL P = 0.078) Methods, limits and fundingOutcomes: Metabolic syndrome prevalence, weight, waist, blood pressure, triglycerides, glucose, HDL cholesterol Limitations: Open-label (people knew their group); six weeks; one centre. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Nyman 2020 Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis-Randomized Controlled Trial. Crohns Colitis 360 · PMID 36777965 · DOI |
Controlled trial |
94 94 people with ulcerative colitis in remission who finished the trial (47 per group) |
Oat bran products Oat bran Amount not given in the abstract 24 weeks · vs Low-fibre wheat products |
The oat bran group had higher stool butyrate and lower serum LDL, and their gut symptoms did not get worse. In the control group obstipation, reflux and total symptoms increased. Relapse rates were the same on both diets. Oat bran was well tolerated. Higher fecal butyrate and lower LDL with oat bran (P < 0.05); same relapse rate (Not given in the abstract) Methods, limits and fundingOutcomes: Stool butyrate, LDL cholesterol, gut symptoms, relapse Limitations: Small, 24 weeks, and the comparison was low-fibre wheat products, so the result may partly reflect the control diet. Blinding not stated in the abstract. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Pinto-Sanchez 2017 Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology · PMID 28431885 · DOI |
Systematic review meta analysis |
661 28 studies in people with celiac disease (6 randomised and 2 non-randomised trials, 661 patients, plus observational studies) |
Oats added to a gluten-free diet Pure (uncontaminated) oats in all randomised trials Not given in the abstract 12 months in the pooled analysis · vs Gluten-free diet without oats |
Eating pure oats for 12 months did not change symptoms, gut biopsy scores or blood antibody tests in people with celiac disease. The quality of the evidence was low. Symptom score SMD -0.22 (SMD 95% CI -0.56 to 0.13; P = .22) Methods, limits and fundingOutcomes: Symptoms, gut biopsy findings, antibodies Limitations: Low-quality evidence; few studies for many endpoints. All randomised trials used pure oats, so the result does not cover oats that may be contaminated with wheat, barley or rye. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Tan 2024 Differently Processed Low Doses of beta-Glucan from Oat Bran Similarly Attenuate Postprandial Glycemic Response. Foods · PMID 39594039 · DOI |
Crossover trial |
20 20 participants in a crossover design |
Cocoa malt drinks made with intact or processed oat bran, against a drink with no oat bran Oat bran in a drink Low-dose beta-glucan in a drink (single-meal test, not advice) Single test drinks, measured over 4 hours · vs Drink without oat bran |
Three-hour blood sugar response was 26% to 38% lower with the oat bran drinks than with the drink without oat bran, and insulin levels were lower. Glucose iAUC -26% (intact oat bran) to -38% (extruded) (Not given in the abstract) Methods, limits and fundingOutcomes: Blood sugar and insulin responses, gut hormones Limitations: Twenty people, single test drinks, not long-term. Industry-funded. Funding and conflicts: Funded by Nestle R&D Center (Pte) Ltd; several authors are Nestle employees. Read: abstract |
| Whitehead 2014 Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr · PMID 25411276 · DOI |
Systematic review meta analysis |
28 randomised trials of oat beta-glucan (OBG) against a control diet | Oat beta-glucan in oat foods and products, at least 3 g a day Oat beta-glucan (not oat bran alone) Trial range 3.0 to 12.4 g of beta-glucan a day (trial detail, not advice) 2 to 12 weeks · vs Appropriate control diet |
Beta-glucan of 3 g a day or more lowered LDL and total cholesterol compared with control, with no significant effect on HDL cholesterol or triglycerides. LDL lowering was greater when baseline LDL was higher. LDL -0.25 mmol/L; total cholesterol -0.30 mmol/L (LDL 95% CI -0.30 to -0.20; total 95% CI -0.35 to -0.24; P < 0.0001 for both) Methods, limits and fundingOutcomes: LDL, total, HDL cholesterol and triglycerides Limitations: The abstract does not separate oat bran from other oat foods. The searches included in-house study reports from CreaNutrition AG, a company with a commercial interest in oat beta-glucan. Some heterogeneity between trials. Funding and conflicts: Funding is not stated in the abstract. Searches included in-house reports from CreaNutrition AG. Read: abstract |
| Wolever 2018 Effect of adding oat bran to instant oatmeal on glycaemic response in humans - a study to establish the minimum effective dose of oat beta-glucan. Food Funct · PMID 29480316 · DOI |
Crossover trial |
40 40 healthy adults in a randomised crossover design |
Instant oatmeal with oat bran adding 0.2 to 1.6 g oat beta-glucan, against a rice cereal Oat bran added to instant oatmeal Test portions of 0.2, 0.4, 0.8 or 1.6 g added beta-glucan (single-meal test, not advice) Single test meals, glucose measured over 2 hours · vs Instant oatmeal without added bran; cream of rice |
More oat beta-glucan from oat bran went with a smaller blood sugar rise. Each gram of added beta-glucan lowered the 2-hour response by about 7% and the peak rise by about 15%. iAUC -7% and peak rise -15% per gram of oat beta-glucan (1.6 g was needed for 20% lower iAUC; 0.4 g for a 20% lower peak (P < 0.05)) Methods, limits and fundingOutcomes: Blood sugar response over 2 hours (iAUC) and peak rise Limitations: Single meals in healthy people, not a long-term trial and not in people with diabetes. Funding is not stated in the abstract. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Xue 2021 The effect of dietary fiber (oat bran) supplement on blood pressure in patients with essential hypertension: A randomized controlled trial. Nutr Metab Cardiovasc Dis · PMID 34090773 · DOI |
Controlled trial |
50 50 adults with essential hypertension (25 per group) |
Oat bran, one bag a day containing 8.9 g of dietary fibre, plus usual dietary guidance for hypertension Oat bran 30 g oat bran a day (trial detail, not advice) 3 months · vs Dietary guidance only |
Office and 24-hour blood pressure readings were lower in the oat bran group than in the control group. Use of blood pressure medicine was reduced in the oat bran group. Gut bacteria differed between groups. Office systolic P < 0.001; office diastolic P = 0.028 (actual mmHg differences not in the abstract) (Not given in the abstract) Methods, limits and fundingOutcomes: Office and 24-hour blood pressure, antihypertensive drug use, gut bacteria Limitations: Small trial (50 people). Blinding is not stated in the abstract; oat bran vs no supplement, so not placebo-controlled. Size of the blood pressure change is not in the abstract. Funding and conflicts: No competing interests declared. Registered ChiCTR1900024055. Registration: ChiCTR1900024055 Read: abstract |
| Yu 2022 Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients · PMID 35631184 · DOI |
Systematic review meta analysis |
927 13 randomised trials, 927 adults with raised cholesterol |
Oat beta-glucan Oat beta-glucan Trial detail not given in the abstract Not given in the abstract · vs Control |
Oat beta-glucan lowered total cholesterol and LDL cholesterol. It did not change triglycerides or HDL cholesterol. Disease severity, daily amount, source and duration affected the results. Total cholesterol -0.24 mmol/L; LDL -0.27 mmol/L; triglycerides -0.04 mmol/L (not significant); HDL 0.00 mmol/L (Total cholesterol -0.28 to -0.20; LDL -0.35 to -0.20; triglycerides -0.13 to 0.05; HDL -0.05 to 0.05) Methods, limits and fundingOutcomes: Total cholesterol, LDL, HDL, triglycerides Limitations: Oat beta-glucan in general; the authors note limitations in the abstract without listing them. Funding and conflicts: No competing interests declared. Read: abstract |
| Zhang 2026 Avenanthramides in Obesity-Related Metabolic Dysfunction: Mechanisms, Evidence Attribution, and Translational Priorities. Nutrients · PMID 42797048 · DOI |
Narrative review cell, animal and human |
Review of cell, animal, pharmacokinetic and human studies of avenanthramides (oat-specific compounds) | Avenanthramides, from purified compounds to whole oat products Oat compounds |
In cell and animal models avenanthramides affect inflammation, antioxidant and sugar and fat pathways. Human studies show people absorb them from oats. Among the studies appraised, none showed an avenanthramide-specific effect on body fat, liver fat, insulin sensitivity or blood fats. No avenanthramide-specific human effect found (Not applicable) Methods, limits and fundingOutcomes: Fat mass, liver fat, insulin sensitivity, blood fats Limitations: A narrative review. Mostly cell and animal work; human clinical evidence is small enriched-food exercise studies. Funding and conflicts: No conflicts declared. Read: abstract |
| s-efsa-oat-bg-2010 EFSA Panel on Dietetic Products, Nutrition and Allergies: Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol (Article 14), EFSA Journal 2010 · Source |
Regulatory guidance n/a |
Methods, limits and fundingRead: abstract | ||
| s-fda-21cfr101-81 21 CFR 101.81: Health claims: Soluble fiber from certain foods and risk of coronary heart disease · Source |
Regulatory guidance n/a |
Methods, limits and fundingRead: full-text | ||
| s-gbif-avena-sativa GBIF Backbone: Avena sativa L. (usageKey 2705290) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-medlineplus-fiber MedlinePlus: Dietary Fiber · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-medlineplus-foodallergy MedlinePlus: Food Allergy · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-nhs-coeliac NHS: Coeliac disease · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-celiac NIDDK: Eating, Diet, & Nutrition for Celiac Disease · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-ckd NIDDK: Healthy Eating for Adults with Chronic Kidney Disease · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-usda-fdc-168872 USDA FoodData Central: Oat bran, raw (SR Legacy, FDC 168872) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-usda-fdc-168873 USDA FoodData Central: Oat bran, cooked (SR Legacy, FDC 168873) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-usda-fdc-oats USDA FoodData Central: Cereals, oats, regular and quick, dry (FDC 173904) and cooked with water (FDC 173905) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-who-mycotoxins WHO: Mycotoxins (fact sheet, 2 October 2023) · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text |
What we do not know yet
- No analysis of oat bran alone was found for cholesterol; the abstracts report oat beta-glucan in oat foods and products.
- No trial showing fewer heart attacks or strokes from oat bran was found.
- The blood pressure and gestational diabetes results come from single small trials with no size of change in the abstracts.
- No FODMAP, oxalate, histamine, pesticide or heavy metal data for oat bran, and no pregnancy, breastfeeding or choking advice specific to it, were found.
How new research is added
New studies are found by a saved PubMed search and placed in a review queue before the page changes.
Lab markers
What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".
Metabolic 2
LDL cholesterol
Lowered in trials
The "bad" cholesterol carried in the blood. Higher levels are linked to more heart disease.
Moderate certaintyResults and what it means
Why it was measured
It is the usual blood marker in diet trials for heart risk.
Statistical vs. clinical meaning
A small average fall in a blood marker. It is not proof of fewer heart attacks.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 9 | LDL -0.25 mmol/L (95% CI -0.30 to -0.20) | 28 randomised trials | Oat beta-glucan, at least 3 g a day, 2 to 12 weeks |
| 4 | LDL -0.19 mmol/L (95% CI -0.23 to -0.14); considerable heterogeneity (I2 79%) | 58 trials, 3,974 people | Oat beta-glucan, median 3.5 g a day, at least 3 weeks |
| 12 | LDL -0.27 mmol/L (95% CI -0.35 to -0.20) | 13 trials, 927 adults with raised cholesterol | Oat beta-glucan |
Total cholesterol
Lowered in trials
All the cholesterol carried in the blood.
Moderate certaintyResults and what it means
Why it was measured
A standard blood fat measure.
Statistical vs. clinical meaning
A small average fall, mostly the LDL part.
Safety implication
None specific.
Other 4
HDL cholesterol and triglycerides
No clear change in trials
HDL is the "good" cholesterol. Triglycerides are another blood fat.
Moderate certaintyResults and what it means
Why it was measured
Checked to see whether a diet changes the whole blood-fat picture.
Statistical vs. clinical meaning
No benefit or harm on these markers in pooled trials. One trial of oat bran in metabolic syndrome saw HDL fall within the oat bran group (see the other studied uses).
Safety implication
None specific.
Blood sugar after a meal
Lowered in trials
How high blood sugar rises in the hours after eating.
Low certaintyResults and what it means
Why it was measured
A simple test of how a food affects blood sugar.
Statistical vs. clinical meaning
A short-term effect in small studies.
Safety implication
People using diabetes medicine should ask their clinic about diet changes.
| Study | Result | People | Product |
|---|---|---|---|
| 10 | About 7% lower 2-hour response and 15% lower peak per gram of added oat beta-glucan | 40 healthy adults, crossover | Oat bran added to instant oatmeal |
| 8 | 3-hour glucose response 26% to 38% lower than the drink without oat bran | 20 participants, crossover | Malt drinks with intact or processed oat bran (Nestle-funded) |
| 2 | 2-hour glucose lower than control at 2 and 4 weeks (P < 0.001); numbers not in the abstract | 112 women with gestational diabetes | Oat bran with diet for 4 weeks |
Blood pressure
Lowered in trials
The force of blood on artery walls, measured in the clinic or over 24 hours.
Very low certaintyResults and what it means
Why it was measured
High blood pressure raises the risk of heart attack and stroke.
Statistical vs. clinical meaning
One small trial; mmHg changes not in the abstract.
Safety implication
Do not change blood pressure medicine without a clinician.
| Study | Result | People | Product |
|---|---|---|---|
| 11 | Office systolic P < 0.001, office diastolic P = 0.028; less blood pressure medicine used in the oat bran group (P = 0.021) | 50 adults with hypertension | Oat bran 30 g a day for 3 months, plus diet guidance |
Liver fat (CAP)
No change in trials
A scan measure of fat in the liver.
Low certaintyResults and what it means
Why it was measured
It shows how much fat has built up in the liver in fatty liver disease.
Statistical vs. clinical meaning
No added benefit from the fibre.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 3 | No significant change in hepatic steatosis (CAP) with oat bran, spelt bran or placebo | 48 adults with MASLD | Oat bran (4.5 g beta-glucan, 11.7 g fibre a day) for 12 weeks |
Safety
What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.
Main points to know 4
- Gluten cross-contact in oats and oat bran. Oats do not contain gluten, but they can cause a reaction if produced where wheat, barley and rye are handled (NHS). A small number of people with coeliac disease may also react to pure oats (NHS). NIDDK says research suggests most people with celiac disease can safely eat moderate amounts of oats, but cross-contact between oats and gluten grains is common, so choose oats labelled gluten-free and talk to your doctor or dietitian first. In a 2017 review, pure oats eaten for 12 months did not change symptoms, gut biopsies or antibodies in people with celiac disease; the evidence was low quality and used pure oats only. Authoritative guidance 19 20 7
- Gas, bloating and cramps if fibre is added too fast. MedlinePlus says increasing dietary fibre too quickly can lead to gas, bloating and cramps, and advises adding it slowly. In a 24-week trial of oat bran in ulcerative colitis in remission, oat bran was well tolerated. Authoritative guidance 17 6
- Kidney disease: phosphorus and potassium. Oat bran contains phosphorus and potassium: 734 mg and 566 mg per 100 g raw, 119 mg and 92 mg per 100 g cooked (USDA). NIDDK says damaged kidneys cannot remove phosphorus and potassium well, and that people with chronic kidney disease may need to limit foods high in these. Ask your kidney team about oat bran. Authoritative guidance 21 23 22
- Mould toxins and storage. WHO says mycotoxins can be found in cereals, advises discarding grain that looks mouldy, discoloured or shrivelled, and advises buying grain fresh and keeping it dry. WHO notes T-2 and HT-2 toxins are associated with oats. Authoritative guidance 25
Side effects 2
| Effect | How often | Severity and recovery | Evidence |
|---|---|---|---|
| Gas, bloating and cramps from adding fibre too quickly MedlinePlus advises adding fibre slowly. The page is about fibre in general, not oat bran. | Not given in the source | usually mild Not stated | Authoritative guidance 17 |
| Reaction in celiac disease from gluten cross-contact in oat products Choose gluten-free-labelled oat products if you have celiac disease. | Not found | varies Not stated | Authoritative guidance 19 20 |
Liver
No liver injury from eating oat bran as food was found in the sources read. A liver-safety source (such as LiverTox) was not searched for oat bran.
How often. No frequency was found.
Monitoring. No agency monitoring advice was found.
This is a safety connection. It is not evidence that Oat Bran supports liver health.
Medicines and supplements 2
| With | Why it matters | Importance | Evidence | What to do |
|---|---|---|---|---|
| Medicines for diabetes, blood pressure or cholesterol prescription | Small trials of oat bran lowered blood sugar and blood pressure readings, and oat beta-glucan lowers LDL. In theory, big diet changes could add to a medicine's effect. | No source read tied oat bran to a specific medicine interaction. This is a general caution, not a documented interaction. In the blood pressure trial, less blood pressure medicine was used in the oat bran group. | Theoretical Not enough evidence 11 2 | Ask your clinician or pharmacist before big diet changes if you take medicine for diabetes, blood pressure or cholesterol. Do not change medicine yourself. |
| Medicines taken at the same time as high-fibre foods prescription | Not found for oat bran. | No source read states that oat bran changes how medicines are absorbed. | None found Not enough evidence | Ask a pharmacist if you take several medicines. |
Who should check first 2
| Situation | Advice | Evidence |
|---|---|---|
| Celiac disease or gluten sensitivity, with oat bran not labelled gluten-free | Choose oat products labelled gluten-free and ask your doctor or dietitian first. | Authoritative guidance 19 20 |
| Chronic kidney disease on a phosphorus or potassium limit | Ask your kidney team about oat bran. | Authoritative guidance 21 22 |
Overdose, product quality and regulators
Summary. No toxicity from oat bran as ordinary food was found in the sources read. Mould toxins in stored grain are the main food-safety point.
Animal. Not reviewed.
Human doses studied. Oat bran trials ran up to 24 weeks; oat bran was reported as well tolerated in the colitis trial.
Overdose response. Not found.
Genotoxicity. Not researched.
WHO says cereals can carry mycotoxins; T-2 and HT-2 toxins are associated with oats. Gluten cross-contact is the other quality issue for oats.
Mould toxins (mycotoxins) in cereals. WHO says mycotoxins occur in cereals, and advises discarding grain that looks mouldy, discoloured or shrivelled, buying grain fresh, and keeping it dry. 25
Gluten cross-contact. Cross-contact between oats and gluten grains is common (NIDDK); FDA "gluten-free" labelling requires less than 20 parts per million of gluten. 20
| Body | Action | Date |
|---|---|---|
| US FDA (United States) | 21 CFR 101.81 allows a heart-disease label claim for foods with soluble fibre from oat bran (at least 5.5% beta-glucan, dry weight) and other whole oat or barley foods. The wording must say such diets "may" or "might" reduce the risk of heart disease. It is a labelling rule, not personal advice. source | Current regulation text read 2026-10-26 |
| EFSA (European Union) | Found a cause and effect relationship between oat beta-glucan and lowering blood LDL cholesterol; foods should provide at least 3 g of oat beta-glucan a day to bear the claim. The application was from CreaNutrition AG. source | 2010 |
| NHS (United Kingdom) | Oats do not contain gluten but can cause a reaction if produced where wheat, barley and rye are handled; a small number of people with coeliac disease may react to pure oats. source | Page review due 31 March 2026 (may be out of date) |
| NIDDK (United States) | Most people with celiac disease can safely eat moderate amounts of oats; make sure they are gluten-free; talk to your doctor or dietitian. Gluten-free labelling needs less than 20 ppm gluten. source | Reviewed October 2020 |
| WHO (International) | Mycotoxins fact sheet: inspect grains for mould, discard mouldy, discoloured or shrivelled grain, buy fresh and store dry. source | 2023-10-02 |
When to get medical help
- Trouble breathing, swelling of the lips, face or throat, widespread hives, repeated vomiting or collapse after eating a product with oat bran (possible anaphylaxis): call emergency services (911 in the US).
- If you have celiac disease and get ongoing diarrhoea, pain or other symptoms after eating oats: speak to your doctor.
Stop using the product and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.
General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.
Frequently asked questions
What is oat bran good for?
Does oat bran lower cholesterol?
Is oat bran gluten-free?
Is oat bran better than oatmeal?
Can oat bran cause gas or bloating?
Does oat bran help blood sugar?
Does oat bran lower blood pressure?
One small 3-month trial in 50 adults with hypertension found lower readings with oat bran added to diet advice. One trial is not enough to conclude. Do not change blood pressure medicine yourself.
Does oat bran help with weight loss or fatty liver?
Is oat bran okay with kidney disease?
Can you be allergic to oats?
Oats are not on MedlinePlus's list of the most common food allergens. Products with oat bran can contain wheat, milk or nuts, so read the label. For trouble breathing or swelling of the face or throat, call emergency services.
Is oat bran safe in pregnancy?
No pregnancy warning for oat bran was found. One 4-week trial gave oat bran to women with gestational diabetes and reported lower glucose. Ask your doctor or midwife.
Explore by health goal
Heart HealthWeight ManagementCholesterol BalanceDigestive SupportBlood Sugar BalanceBlood Pressure SupportLiver SupportGut Health
Editorial transparency
- Written by
- AlternativeMed editorial team. Research compiled with AI assistance, then checked against the sources listed.
- Medical review
- None. This page has not been reviewed by a physician or pharmacist.
- First published
- 2026-10-26
- Last substantive update
- 2026-10-26
- How we research
- We started from our existing oat bran summary, re-checked nutrition against saved USDA FoodData Central data, read the FDA rule, the EFSA abstract and the NHS, NIDDK, MedlinePlus and WHO pages, and re-read PubMed abstracts for reviews and trials. Only abstracts were read for studies. Items we could not verify are flagged in the research gaps. The EFSA application and one pooled review involved an oat beta-glucan company; one blood sugar trial was funded by Nestle.
- How we rate evidence
- See "How we rate evidence" in the Evidence tab.
- Independence
- No product is promoted on this page. No affiliate links are shown.
Sources 25
Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.
- Aune D, Keum N, Giovannucci E, et al.. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.. BMJ. 2016. PMID 27301975. DOI 10.1136/bmj.i2716. (abstract)
- Barati Z, Iravani M, Karandish M, et al.. The effect of oat bran consumption on gestational diabetes: a randomized controlled clinical trial.. BMC Endocr Disord. 2021. PMID 33849494. DOI 10.1186/s12902-021-00731-8. (abstract)
- Brandt A, Yergaliyev T, Halibasic E, et al.. Fiber enrichment is not superior to dietary monitoring in MASLD: A dual-center, double-blind, placebo-controlled trial.. iScience. 2025. PMID 41438070. DOI 10.1016/j.isci.2025.114019. (abstract)
- Ho HV, Sievenpiper JL, Zurbau A, et al.. The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials.. Br J Nutr. 2016. PMID 27724985. DOI 10.1017/S000711451600341X. (abstract)
- Leao LSCS, Aquino LA, Dias JF, Koifman RJ. Addition of oat bran reduces HDL-C and does not potentialize effect of a low-calorie diet on remission of metabolic syndrome: A pragmatic, randomized, controlled, open-label nutritional trial.. Nutrition. 2019. PMID 31082790. DOI 10.1016/j.nut.2019.03.007. (abstract)
- Nyman M, Nguyen TD, Wikman O, Hjortswang H, Hallert C. Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis-Randomized Controlled Trial.. Crohns Colitis 360. 2020. PMID 36777965. DOI 10.1093/crocol/otaa005. (abstract)
- Pinto-Sanchez MI, Causada-Calo N, Bercik P, et al.. Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies.. Gastroenterology. 2017. PMID 28431885. DOI 10.1053/j.gastro.2017.04.009. (abstract)
- Tan D, Yao Y, Zhou Y, et al.. Differently Processed Low Doses of beta-Glucan from Oat Bran Similarly Attenuate Postprandial Glycemic Response.. Foods. 2024. PMID 39594039. DOI 10.3390/foods13223623. (abstract)
- Whitehead A, Beck EJ, Tosh S, Wolever TM. Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials.. Am J Clin Nutr. 2014. PMID 25411276. DOI 10.3945/ajcn.114.086108. (abstract)
- Wolever TMS, Jenkins AL, Prudence K, et al.. Effect of adding oat bran to instant oatmeal on glycaemic response in humans - a study to establish the minimum effective dose of oat beta-glucan.. Food Funct. 2018. PMID 29480316. DOI 10.1039/c7fo01768e. (abstract)
- Xue Y, Cui L, Qi J, et al.. The effect of dietary fiber (oat bran) supplement on blood pressure in patients with essential hypertension: A randomized controlled trial.. Nutr Metab Cardiovasc Dis. 2021. PMID 34090773. DOI 10.1016/j.numecd.2021.04.013. (abstract)
- Yu J, Xia J, Yang C, et al.. Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Nutrients. 2022. PMID 35631184. DOI 10.3390/nu14102043. (abstract)
- Zhang X, Sun H, Tao B, et al.. Avenanthramides in Obesity-Related Metabolic Dysfunction: Mechanisms, Evidence Attribution, and Translational Priorities.. Nutrients. 2026. PMID 42797048. DOI 10.3390/nu18183066. (abstract)
- . EFSA Panel on Dietetic Products, Nutrition and Allergies: Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol (Article 14), EFSA Journal 2010. . . (abstract)
- . 21 CFR 101.81: Health claims: Soluble fiber from certain foods and risk of coronary heart disease. . . (full-text)
- . GBIF Backbone: Avena sativa L. (usageKey 2705290). . . (full-text)
- . MedlinePlus: Dietary Fiber. . . (full-text)
- . MedlinePlus: Food Allergy. . . (full-text)
- . NHS: Coeliac disease. . . (full-text)
- . NIDDK: Eating, Diet, & Nutrition for Celiac Disease. . . (full-text)
- . NIDDK: Healthy Eating for Adults with Chronic Kidney Disease. . . (full-text)
- . USDA FoodData Central: Oat bran, raw (SR Legacy, FDC 168872). . . (full-text)
- . USDA FoodData Central: Oat bran, cooked (SR Legacy, FDC 168873). . . (full-text)
- . USDA FoodData Central: Cereals, oats, regular and quick, dry (FDC 173904) and cooked with water (FDC 173905). . . (full-text)
- . WHO: Mycotoxins (fact sheet, 2 October 2023). . . (full-text)
Where to buy
Check the label first. Whatever you buy, look for these:
- Whole grain listed first, with no added sugar
- Gluten-free labeling if you need it, since cross-contact is common
- A best-by date and airtight storage
- Allergen statements
Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.
Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.